Renata Nogueira Costa, NP
Psychiatric/Mental Health · San Francisco
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 14
- 1 carrier
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
14 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Renata Nogueira Costa’s office at (855) 313-0305 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Medicaid work
$37,201 in 2024
Medicaid paid $37,201 for 219 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 126 | $23,245 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 93 | $13,956 |
| 2024 | 219 | 2 | 15 | $37,201 |
| 2023 | 86 | 2 | 14 | $9,393 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 47 | $5,800 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 39 | $3,593 |
Drugs they prescribed that Part D paid
$24,734
Pharmacies billed $24,734 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 149) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
136 generic and 13 brand-name prescriptions · $24,734 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lybalvi | 13 | $20,183 | $1,553 |
| Lurasidone | 13 | $2,508 | $193 |
| Dextroamphetamine-Amphet Er | 11 | $419 | $38 |
| Escitalopram | 16 | $184 | $11 |
| Gabapentin | 14 | $176 | $13 |
See all 6 drugs
| Lybalvi | 13 | $20,183 | $1,553 |
| Lurasidone | 13 | $2,508 | $193 |
| Dextroamphetamine-Amphet Er | 11 | $419 | $38 |
| Escitalopram | 16 | $184 | $11 |
| Gabapentin | 14 | $176 | $13 |
| Sertraline | 13 | $50 | $4 |
Year by year
| 2024 | 149 | None | 0% (0) | 9% | $24,734 |
| 2023 | 40 | None | 0% (0) | None | $8,042 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$2,509 in 2025
| 2025 | 11 | 143 | None | $2,509 |
| 2024 | 13 | 44 | None | $1,088 |
| 2023 | 1 | 1 | None | $14 |
| 2022 | 3 | 6 | $550 | $691 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch Health US | Aplenzin | $1,020 | 55 payments
|
| Vanda Pharmaceuticals | Fanapt | $362 | 16 payments
|
| Abbvie | Vraylar | $314 | 27 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $258 | 19 payments
|
| Axsome Therapeutics | Auvelity | $237 | 12 payments
|
| Neurocrine BioSciences | Ingrezza | $84 | 4 payments
|
See all 143 published payments
| Bausch Health US | Meals · 2025-12-22 | Aplenzin | $23 |
| Bausch Health US | Meals · 2025-12-22 | Aplenzin | $23 |
| Abbvie | Meals · 2025-12-03 | Vraylar | $28 |
| Axsome Therapeutics | Meals · 2025-12-02 | Auvelity | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-02 | Caplyta | $27 |
| Bausch Health US | Meals · 2025-11-24 | Aplenzin | $20 |
| Bausch Health US | Meals · 2025-11-24 | Aplenzin | $17 |
| Bausch Health US | Meals · 2025-11-24 | Aplenzin | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-20 | Cobenfy | $15 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-18 | Cobenfy | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-11-12 | Rexulti | $29 |
| Axsome Therapeutics | Meals · 2025-11-12 | Auvelity | $26 |
| Abbvie | Meals · 2025-11-11 | Vraylar | $13 |
| Bausch Health US | Meals · 2025-11-10 | Aplenzin | $16 |
| Bausch Health US | Meals · 2025-11-10 | Aplenzin | $13 |
| Bausch Health US | Meals · 2025-11-06 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-11-06 | Aplenzin | $25 |
| Abbvie | Meals · 2025-11-04 | Vraylar | $11 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-04 | Caplyta | $4 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-04 | Caplyta | $0 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-04 | Caplyta | $0 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-04 | Caplyta | $19 |
| Axsome Therapeutics | Meals · 2025-10-30 | Auvelity | $33 |
| Bausch Health US | Meals · 2025-10-30 | Aplenzin | $20 |
| Abbvie | Meals · 2025-10-22 | Vraylar | $18 |
| Bausch Health US | Meals · 2025-10-20 | Aplenzin | $23 |
| Alkermes | Meals · 2025-10-17 | Lybalvi | $26 |
| Axsome Therapeutics | Meals · 2025-10-15 | Auvelity | $20 |
| Abbvie | Meals · 2025-10-14 | Vraylar | $9 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-14 | Caplyta | $31 |
| Neurocrine BioSciences | Meals · 2025-10-14 | Ingrezza | $21 |
| Bausch Health US | Meals · 2025-10-13 | Aplenzin | $25 |
| Abbvie | Meals · 2025-10-10 | Vraylar | $18 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $7 |
| Vanda Pharmaceuticals | Meals · 2025-10-07 | Fanapt | $13 |
| Bausch Health US | Meals · 2025-09-29 | Aplenzin | $19 |
| Bausch Health US | Meals · 2025-09-29 | Aplenzin | $17 |
| Bausch Health US | Meals · 2025-09-22 | Aplenzin | $19 |
| Bausch Health US | Meals · 2025-09-22 | Aplenzin | $23 |
| Bausch Health US | Meals · 2025-09-10 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-09-10 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-09-10 | Aplenzin | $17 |
| Abbvie | Meals · 2025-09-09 | Vraylar | $11 |
| Bausch Health US | Meals · 2025-09-08 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-09-08 | Aplenzin | $20 |
| Bausch Health US | Meals · 2025-09-08 | Aplenzin | $20 |
| Neurocrine BioSciences | Meals · 2025-09-06 | Ingrezza | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-03 | Caplyta | $26 |
| Vanda Pharmaceuticals | Meals · 2025-08-26 | Fanapt | $27 |
| Vanda Pharmaceuticals | Meals · 2025-08-22 | Fanapt | $33 |
| Bausch Health US | Meals · 2025-08-19 | Aplenzin | $15 |
| Bausch Health US | Meals · 2025-08-19 | Aplenzin | $14 |
| Bausch Health US | Meals · 2025-08-19 | Aplenzin | $22 |
| Bausch Health US | Meals · 2025-08-18 | Aplenzin | $22 |
| Bausch Health US | Meals · 2025-08-18 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-08-18 | Aplenzin | $20 |
| Abbvie | Meals · 2025-08-16 | Vraylar | $13 |
| Axsome Therapeutics | Meals · 2025-08-16 | Auvelity | $35 |
| Bausch Health US | Meals · 2025-08-12 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-08-12 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-08-12 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-08-12 | Aplenzin | $15 |
| Otsuka America Pharmaceutical | Meals · 2025-08-06 | Rexulti | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-06 | Caplyta | $0 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-06 | Caplyta | $13 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-06 | Caplyta | $2 |
| Abbvie | Meals · 2025-08-05 | Vraylar | $7 |
| Vanda Pharmaceuticals | Meals · 2025-08-05 | Fanapt | $9 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-01 | Caplyta | $4 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-01 | Caplyta | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-01 | Caplyta | $2 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-28 | Cobenfy | $25 |
| Bausch Health US | Meals · 2025-07-28 | Aplenzin | $22 |
| Bausch Health US | Meals · 2025-07-28 | Aplenzin | $24 |
| Bausch Health US | Meals · 2025-07-28 | Aplenzin | $17 |
| Axsome Therapeutics | Meals · 2025-07-22 | Auvelity | $14 |
| Bausch Health US | Meals · 2025-07-21 | Aplenzin | $12 |
| Bausch Health US | Meals · 2025-07-21 | Aplenzin | $15 |
| Abbvie | Meals · 2025-07-19 | Vraylar | $17 |
| Abbvie | Meals · 2025-07-16 | Vraylar | $25 |
| Axsome Therapeutics | Meals · 2025-07-16 | Auvelity | $21 |
| Vanda Pharmaceuticals | Meals · 2025-07-15 | Fanapt | $23 |
| Bausch Health US | Meals · 2025-07-15 | Aplenzin | $19 |
| Bausch Health US | Meals · 2025-07-15 | Aplenzin | $24 |
| Neurocrine BioSciences | Meals · 2025-07-15 | Ingrezza | $19 |
| Bausch Health US | Meals · 2025-07-14 | Aplenzin | $15 |
| Bausch Health US | Meals · 2025-07-14 | Aplenzin | $1 |
| Bausch Health US | Meals · 2025-07-14 | Aplenzin | $4 |
| Abbvie | Meals · 2025-07-08 | Vraylar | $12 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-08 | Caplyta | $18 |
| Abbvie | Meals · 2025-07-01 | Vraylar | $6 |
| Abbvie | Meals · 2025-07-01 | Vraylar | $4 |
| Abbvie | Meals · 2025-07-01 | Vraylar | $2 |
| Axsome Therapeutics | Meals · 2025-06-27 | Auvelity | $35 |
| Lundbeck | Meals · 2025-06-17 | Rexulti | $18 |
| Vanda Pharmaceuticals | Meals · 2025-06-16 | Fanapt | $28 |
| Bausch Health US | Meals · 2025-06-16 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-06-16 | Aplenzin | $16 |
| Janssen Pharmaceuticals | Meals · 2025-06-10 | Invega Sustenna | $29 |
| Bausch Health US | Meals · 2025-06-10 | Aplenzin | $18 |
| Bausch Health US | Meals · 2025-06-10 | Aplenzin | $18 |
| Vanda Pharmaceuticals | Meals · 2025-05-27 | Fanapt | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-27 | Caplyta | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-23 | Caplyta | $30 |
| Bausch Health US | Meals · 2025-05-20 | Aplenzin | $23 |
| Vanda Pharmaceuticals | Meals · 2025-05-14 | Fanapt | $12 |
| Axsome Therapeutics | Meals · 2025-05-14 | Auvelity | $1 |
| Axsome Therapeutics | Meals · 2025-05-13 | Auvelity | $15 |
| Bausch Health US | Meals · 2025-05-12 | Aplenzin | $15 |
| Abbvie | Meals · 2025-05-07 | Vraylar | $7 |
| Axsome Therapeutics | Meals · 2025-05-07 | Auvelity | $1 |
| Abbvie | Meals · 2025-05-01 | Vraylar | $17 |
| Bausch Health US | Meals · 2025-04-28 | Aplenzin | $16 |
| Bausch Health US | Meals · 2025-04-28 | Aplenzin | $5 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-28 | Caplyta | $19 |
| Vanda Pharmaceuticals | Meals · 2025-04-25 | Fanapt | $29 |
| Abbvie | Meals · 2025-04-22 | Vraylar | $9 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $1 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $22 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $24 |
| Vanda Pharmaceuticals | Meals · 2025-04-14 | Fanapt | $14 |
| Abbvie | Meals · 2025-04-09 | Vraylar | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-26 | Caplyta | $22 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-26 | Caplyta | $1 |
| Abbvie | Meals · 2025-03-25 | Vraylar | $10 |
| Vanda Pharmaceuticals | Meals · 2025-03-25 | Fanapt | $33 |
| Abbvie | Meals · 2025-03-22 | Vraylar | $11 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $23 |
| Abbvie | Meals · 2025-03-12 | Vraylar | $8 |
| Alkermes | Meals · 2025-03-11 | Aristada | $23 |
| Vanda Pharmaceuticals | Meals · 2025-03-11 | Fanapt | $32 |
| Abbvie | Meals · 2025-02-25 | Vraylar | $10 |
| Vanda Pharmaceuticals | Meals · 2025-02-25 | Fanapt | $28 |
| Abbvie | Meals · 2025-02-19 | Vraylar | $7 |
| Vanda Pharmaceuticals | Meals · 2025-02-18 | Fanapt | $21 |
| Janssen Pharmaceuticals | Meals · 2025-02-13 | Spravato | $28 |
| Bausch Health US | Meals · 2025-02-12 | Aplenzin | $15 |
| Vanda Pharmaceuticals | Meals · 2025-02-05 | Fanapt | $16 |
| Abbvie | Meals · 2025-01-28 | Vraylar | $15 |
| Axsome Therapeutics | Meals · 2025-01-28 | Auvelity | $16 |
| Neurocrine BioSciences | Meals · 2025-01-21 | Ingrezza | $20 |
| Abbvie | Meals · 2025-01-18 | Vraylar | $15 |
| Vanda Pharmaceuticals | Meals · 2025-01-07 | Fanapt | $18 |
See earlier years (2024, 2023, 2022)
2024: $1,088
| Abbvie | Vraylar | $308 | 14 payments
|
| Vanda Pharmaceuticals | Fanapt | $245 | 6 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $94 | 4 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $81 | 3 payments
|
| Lundbeck | Rexulti | $76 | 4 payments
|
| Alkermes | Aristada | $68 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $64 | 3 payments
|
| Supernus Pharmaceuticals | Qelbree | $40 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $26 | 1 payment
|
| Axsome Therapeutics | Auvelity | $24 | 1 payment
|
| Almatica Pharma | Loreev Xr | $23 | 1 payment
|
| Bausch Health US | Aplenzin | $23 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $16 | 1 payment
|
2023: $14
| Bausch Health US | Aplenzin | $14 | 1 payment
|
2022: $691
| Janssen Research & Development | Stelara | $300 | 1 payment
|
| Resmed | Air 11 | $250 | 1 payment
|
| Stryker | Stryker | $141 | 4 payments
|
Professional record
- NPI
- 1063998284
- Licence
- CA 95003811
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 870 Market St Ste 1241, San Francisco, CA, 94102
- NPI first listed
- 2018-07-11
- NPI last updated
- 2026-02-25
- NPI record certified
- 2026-02-25
This is when the NPI record was last certified, not a medical board exam.